As ANDA Suit Venue Options Shrink, Del., NJ Rule For Now
One year after the Federal Circuit limited venue options for patent suits over generic drugs, a new ruling has clamped down further. But so far, most cases are still being filed...To view the full article, register now.
Already a subscriber? Click here to view full article